qualitech healthcare - medical device provider of the year

---

Nicki Dill, our Managing Director recently attended an Academy for Healthcare Science Reception at the House of Lords and was delighted to be presented with the Academy’s “Chairman’s Award 2023", in recognition of her contribution to the AHCS.

Medovate, a Cambridge based manufacturer of innovative medical technologies created from within the NHS, has concluded an agreement with Qualitech Healthcare to support the roll out of the innovative SAFIRA® system to hospitals in the UK.

Developed in collaboration with NHS clinical innovators, the SAFIRA® system is helping to revolutionise standard regional anaesthesia clinical practice. Regional anaesthesia (RA) is widely used to make a specific part of the body numb to relieve pain or allow surgical procedures to be carried out.

Since UK launch in early 2021, interest in the innovative SAFIRA® system has grown at pace, especially following the Health Services Journal (HSJ) award for ‘Patient Safety Innovation of the Year 2021’. The new partnership with Qualitech Healthcare marks a significant further step in making this innovative medical technology available to healthcare providers to help deliver patient safety benefits and potential cost savings. 

Qualitech Healthcare has proven expertise in supporting the introduction of quality and innovative medical devices for adoption and use in clinical settings to benefit both clinicians and patients. Through this new agreement the Berkshire based company will support both the positioning of the benefits of the SAFIRA® system to NHS and private hospitals and support ongoing roll out of clinical evaluations and adoption discussion using their experienced team of Clinical Specialists across the UK. 

  The award winning SAFIRA® system revolutionises current practice in a number of ways. First, it makes the current two-person procedure a one-person procedure by giving anaesthetists full control without the need for an assistant. The technology also incorporates a unique safety feature that monitors injection pressure, automatically stopping injection at pressures above a calibrated pressure threshold to reduce the risk of nerve damage. Furthermore, economic modelling has shown the SAFIRA® system to have the potential to help deliver significant cost savings.

Following agreement of the new partnership, at the recent Association of Anaesthetists Winter Scientific Meeting (WSM) 2023 in London members of both the Medovate and Qualitech Healthcare teams were in attendance to talk with regional anaesthesia practitioners about the benefits the revolutionary SAFIRA® system can provide.